Actual Medicinal Product (AMP) - Xeljanz 11mg modified-release tablets (Pfizer Ltd)
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Xeljanz 11mg modified-release tablets | Start Date 21-02-2020 | End Date |
Summary
- Licensed Route
- Oral
- Availability Restrictions
- None
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
Codes
| Code | Start Date | End Date |
|---|---|---|
| 38101111000001109 | 21-02-2020 |
Parent Products
-
VTMTofacitinib
-
VMPTofacitinib 11mg modified-release tablets
-
AMP(Current) Xeljanz 11mg modified-release ...
-
-
Actual Medicinal Product Pack (AMPP) Information
| Pack Size | Indicative Price | Discontinued |
|---|---|---|
| 28 tablet | 69003 |